Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. Airway disease is the major source of morbidity and mortality. Successful implementation of gene-and cell-based therapies for CF airway disease requires knowledge of relationships among percentages of targeted cells, levels of CFTR expression, correction of electrolyte transport, and rescue of host defense defects. Previous studies suggested that, when ∼10-50% of airway epithelial cells expressed CFTR, they generated nearly wild-type levels of Cl − secretion; overexpressing CFTR offered no advantage compared with endogenous expression levels. However, recent discoveries focused attention on CFTR-mediated HCO 3 − secretion and airway surface liquid (ASL) pH as critical for host defense and CF pathogenesis. Therefore, we generated porcine airway epithelia with varying ratios of CF and wild-type cells. Epithelia with a 50:50 mix secreted HCO 3 − at half the rate of wild-type epithelia. Likewise, heterozygous epithelia (CFTR +/− or CFTR
+/ΔF508
) expressed CFTR and secreted HCO 3 − at ∼50% of wild-type values. ASL pH, antimicrobial activity, and viscosity showed similar relationships to the amount of CFTR. Overexpressing CFTR increased HCO 3 − secretion to rates greater than wild type, but ASL pH did not exceed wild-type values. Thus, in contrast to Cl − secretion, the amount of CFTR is rate-limiting for HCO 3 − secretion and for correcting host defense abnormalities. In addition, overexpressing CFTR might produce a greater benefit than expressing CFTR at wild-type levels when targeting small fractions of cells. These findings may also explain the risk of airway disease in CF carriers.
cystic fibrosis | gene therapy | host defense | pig | epithelia C ystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) (1) (2) (3) . CFTR is an anion channel expressed in multiple cell types, including the apical membrane of airway epithelia. Loss of CFTR function in airway epithelia impairs host defense, which causes bacterial infection, inflammation, mucus accumulation, obstruction, and remodeling, the major sources of CF morbidity and mortality. Although there has been significant progress in treating people with CF, the disease continues to shorten lives.
Potential genetic-based treatments for CF lung disease include gene transfer of a wild-type (WT) CFTR cDNA (gene therapy) (4) (5) (6) , correction of the CFTR gene sequence (genome editing) (7), repair of CFTR mRNA (8) , and stem-cell transplantation to airways (9) . Gene-and cell-based approaches have potential for long-lasting benefits and are applicable for all CFTR genotypes, but they are limited by CFTR restoration to a limited number of cells. Consequently, a major question is what percentage of cells must express CFTR to reverse CF airway host defense defects.
Previous studies have begun to address this question. Several studies used viral vectors to overexpress CFTR in CF airway epithelial cells and then examined the relationship between the percentage of transduced cells and transepithelial Cl − secretion. Johnson et al. (10) used a retrovirus to overexpress CFTR in an immortalized CF epithelial cell line and measured forskolinstimulated Cl − secretion as the cAMP-induced change in shortcircuit current [ΔIsc (cAMP) ]. They found that, when ∼10% of the cells overexpressed CFTR, ΔIsc (cAMP) was ∼60% of WT levels and that ∼50% of cells overexpressing CFTR generated ∼80% of WT ΔIsc (cAMP) . Goldman et al. (11) used an adenovirus vector to overexpress CFTR in airway epithelial xenografts. They found that CFTR expression in ∼7% of cells generated changes in transepithelial voltage, in the presence of a Cl − concentration gradient, that were ∼75% of voltage changes in non-CF xenografts. Zhang et al. (12) used a parainfluenza virus to overexpress CFTR in cultured human CF airway epithelia. ΔIsc (cAMP) progressively increased as the percentage of transduced epithelial cells increased. When 60% of the cells were transduced (the highest level tested), the ΔIsc (cAMP) was plateauing, although there was no comparison with WT epithelia. Farmen et al. (13) approached this question differently by generating airway epithelia with varying ratios of CF and non-CF airway epithelial cells (which express CFTR at endogenous levels) and measuring transepithelial Cl − secretion. They found that
Significance
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations cause cystic fibrosis (CF), and airway infections cause most morbidity. In airways, the CFTR forms a channel that secretes chloride and bicarbonate. A persistent question for CF gene-and cell-based therapies is how much CFTR is needed to correct host defense defects that predispose to infection. In addressing this question, we were informed by discoveries that, without CFTR-mediated bicarbonate secretion, liquid covering airways becomes abnormally acidic, which impairs airway host defenses. By studying airway epithelia from CF, non-CF, and CFTR heterozygote piglets, we found a relatively linear relationship between amounts of CFTR, bicarbonate secretion, and host defense properties. The results have direct implications for developing therapeutics. They may also explain the risk of airway disease in CF carriers.
epithelia containing 50-60% of non-CF cells had Cl − secretion rates equal to non-CF epithelia. Dannhoffer et al. (14) mixed 10% non-CF cells with 90% CF cells and found that ΔIsc (cAMP) was ∼90% of non-CF values. Taken together, the presence of CFTR in ∼10-50% of airway epithelial cells, even at endogenous levels, generated a transepithelial Cl − secretory current that was approximately the same as that in non-CF airway epithelia. Finding that overexpressing CFTR in a fraction of cells and that expressing CFTR at endogenous levels in a fraction of cells generated similar Cl − secretion rates suggested that, for purposes of gene therapy, overexpressing CFTR confers no advantage compared with endogenous levels of expression. The plateau of Cl − secretion when 10-50% of the cells express CFTR is explained by a limitation to Cl − entry into cells at the basolateral membrane and anion movement between cells through gap junctions (13) .
A related question is how much CFTR should be expressed in individual cells. That is, on a per cell basis, are greater than WT levels of CFTR more efficacious at correcting host defense defects? One approach to answering this question is to study airway epithelia from people who are heterozygous for a CF-causing mutation (CF carriers). A few studies in humans and mice measured transepithelial voltage (Vt) across nasal epithelia before and during perfusion of a solution that is Cl − -free and contains an agent to increase cellular levels of cAMP to phosphorylate and activate CFTR (15) (16) (17) (18) . Two reports also studied cultured mouse and human cells (17, 18) . Most, but not all, studies found no differences between control and CFTR heterozygotes. However, conclusions from those studies are limited because Vt does not provide a quantitative measure of ion transport, mice do not develop CF airway disease, and infection and inflammation may produce secondary alterations in transepithelial electrolyte transport. Despite evidence of similar Cl − transport, CF carriers are predisposed to airway sinus disease (19) (20) (21) , bronchiectasis (22, 23) , and asthma (24) (25) (26) (27) . Those findings suggest that airway host defense might be impaired in CF carriers and that measures of transepithelial Cl − secretion may not be sufficiently sensitive to detect a mild abnormality.
We recently developed CFTR −/− and CFTR ΔF508/ΔF508 pigs (28, 29) . At birth, their airways lack infection and inflammation, but, over the ensuing weeks and months, they develop the hallmark features of CF airway disease (30) . By studying newborn CF piglets, we identified at least two airway host defense defects (2) . Mucociliary transport is impaired by mucus with abnormal biophysical properties (31, 32) , and the activity of airway surface liquid (ASL) antimicrobials and synergism between antimicrobials are impaired (33, 34) . CF ASL has an abnormally low pH, which reduces the activity of ASL antimicrobials and increases the viscosity of ASL. The abnormally acidic ASL pH results from loss of CFTR-mediated HCO 3 − secretion in the presence of continued H + secretion (35) . CFTR is also key for HCO 3 − secretion and alkalization of ASL pH in small airways (36) .
The importance of HCO 3 − secretion for airway host defense suggested that knowing the relationship between CFTR expression and HCO 3 − secretion might inform development of gene-and cellbased therapies. Therefore, we asked what percentage of airway epithelial cells expressing CFTR and what level of CFTR expression would rescue defective HCO 3 − secretion and restore abnormalities related to airway host defense. We studied three epithelial models. ) cells in varying ratios. In the WT cells, CFTR was expressed at endogenous levels; endogenous expression levels are low, with an estimate of 1-2 CFTR transcripts per cell (37) . (ii) We cultured epithelia composed entirely of heterozygous (CFTR +/− or CFTR
) cells. (iii) We produced CF, heterozygous, and WT epithelia that overexpressed CFTR in a small fraction of cells after adenovirus-mediated gene transfer.
Results

HCO 3
− Secretion and Cl − Secretion Show Different Relationships to CFTR Expression. We generated primary cultures of airway epithelia from newborn pigs. They were grown at the air-liquid interface and differentiated and were studied at least 2 wk after seeding as previously reported (38, 39) . We used newborn pigs to avoid secondary changes that might ensue from infection, inflammation, and airway remodeling. To determine the relationship between CFTR expression and anion secretion, we studied epithelia with varying ratios of CFTR −/− (CF) and CFTR +/+ (WT) cells. Because the most common CFTR mutation in humans is deletion of phenylalanine at position 508 (ΔF508) (3), we also examined airway epithelia produced by mixing cells from CFTR ΔF508/ΔF508 pigs with cells from CFTR +/+ littermates (29). After epithelia were studied, quantitative PCR of genomic DNA indicated that the percentages of CF and WT cells in epithelia were as predicted by the seeding ratio (Fig. 1A) . In addition, CFTR mRNA and CFTR protein paralleled the percentage of WT cells ( Fig. 1 B-D) . We measured short-circuit current (Isc) in Ussing chambers after addition of forskolin and 3-isobutyl-1-methylxanthine (IBMX). These agents elevate cellular levels of cAMP leading to phosphorylation and activation of CFTR and stimulation of anion secretion (40) .
As cAMP-stimulated HCO 3 − secretion continued to increase until 100% of the cells were WT (Fig. 2 C and D) . Fifty % of WT cells generated ∼50% of WT HCO 3 − secretion. This pattern was similar when the CF cells were either CFTR −/− or CFTR
ΔF508/ΔF508
. We also studied epithelia composed entirely of heterozygous (CFTR +/− and CFTR +/ΔF508 ) cells. Consistent with the finding that heterozygous epithelia contain half as much WT CFTR mRNA as WT epithelia (Fig. 1B) (41) , heterozygous epithelia had half as much CFTR protein as CFTR +/+ epithelia ( Fig. 1 C and D) . cAMP stimulated Cl − secretion to levels similar to CI − secretion in WT epithelia ( Fig. 2 A and B) . In contrast, cAMP stimulated HCO 3 − secretion to levels half those generated in WT epithelia (Fig. 2 C  and D) . Thus, 50% of CFTR generated ∼50% of the HCO 3 − secretion observed in WT epithelia. This result occurred both when 100% of the cells expressed CFTR at 50% of WT levels (i.e., heterozygous epithelia) and when 50% of the cells expressed CFTR at 100% of WT levels (i.e., mixtures of CF and WT cells). These results contrast with measures of Cl − secretion in which 50% of CFTR generated ∼100% of the Cl − secretion observed in WT epithelia. Airway epithelia also absorb Na + through amiloride-inhibitable apical epithelial Na + channels (ENaCs) (2) . In porcine and human epithelia, apical amiloride produces a greater change in Isc in CF than non-CF because of the lack of a Cl − conductance (42, 43) . Previous studies used gene transfer vectors to overexpress CFTR in human CF epithelia and measured basal transepithelial electrical properties or the amiloride-induced reduction in Isc [ΔIsc (amiloride) ]. The results have varied widely. One study found that expressing CFTR in ∼10% of cells produced a near maximal reduction in ΔIsc (amiloride) (10) . In contrast, a different study reported that CFTR expression in all of the cells reduced ΔIsc (amiloride) , but there was no relationship to vector dose (44) . Between those extremes, one study reported that, as the percentage of transduced cells increased (∼60% was the highest percentage tested), ΔIsc (amiloride) progressively decreased (12) . Another study reported variable effects of CFTR expression on basal transepithelial voltage in CF xenografts (11) .
In a Cl − (HCO 3 − -free) solution, ΔIsc (amiloride) decreased as the percentage of WT cells increased (Fig. 2E) . However, the amiloride-induced reduction in transepithelial electrical conductance ΔGt (amiloride) was not affected (Fig. 2F) . These results are consistent with an effect of the Cl − conductance on ΔIsc (amiloride) , rather than changes in ENaC activity (42, 43) . Those data and that conclusion predicted that removing Cl − would eliminate the relationship between percentage of WT cells and ΔIsc (amiloride). Indeed, compared with a 140-mM Cl − solution, in a solution containing 25 mM HCO 3 − , which has a lower permeability through CFTR than Cl − , there was no relationship between the percentage of WT cells and ΔIsc (amiloride) or ΔGt (amiloride) (Fig. 2 E and F) .
Increasing CFTR Expression Progressively Enhances ASL Host Defense
Properties. To establish the relationship between the percentage of WT cells in an epithelium and assays related to host defense, we did several studies.
As previously reported (32, 33) , CFTR −/− epithelia had a lower ASL pH than CFTR +/+ epithelia (Fig. 3A) . A reduced ASL pH inhibits the activity of ASL antimicrobials, which impairs bacterial killing (33, 34) . We previously developed an assay of ASL antimicrobial activity in which a small gold grid with attached bacteria is briefly touched to the ASL in vivo or in vitro and removed, and the percentage of nonviable bacteria is counted (33, 34) . We routinely use Staphylococcus aureus because it more commonly infects the airways of young children with CF and neonatal CF piglets than Pseudomonas aeruginosa (30, 45) . However, we have observed similar pH-dependent killing of P. aeruginosa (33, 34) . Compared with WT epithelia, bacterial killing was reduced in CF epithelia (Fig. 3B) . Epithelia with mixed cell types showed intermediate levels of bacterial killing, consistent with the rates of HCO 3 − secretion and ASL pH. CF mucus has altered properties that impair mucociliary transport (31) . Recent studies showed that CF ASL has an increased viscosity due to a reduced ASL pH (32, 35) . In epithelia composed of mixtures of CFTR −/− and CFTR +/+ cells, the relationship between the percentage of WT cells and ASL viscosity (τ ASL /τ saline ) approximately paralleled that of ASL pH (Fig. 3C) . Variations − /5% CO 2 and were Cl − -free. Data are mean ± SEM of changes in short-circuit current (ΔIsc) induced by adding 10 μM forskolin and 100 μM IBMX apically to increase intracellular levels of cAMP. To allow comparison between multiple groups of mixed epithelia, data were normalized for each group of epithelia so that ΔIsc for CF (CFTR −/− and CFTR ΔF508/ΔF508 ) epithelia was set at 0% and ΔIsc for epithelia composed entirely of WT cells was set at 100%. For epithelia containing 100% CF cells and 100% WT cells, respectively, the mean ± SEM ΔIsc were as follows: (A) 0.7 ± 0.1 μA·cm in viscosity were not due to differences in ASL depth (Fig.  3D) (42) .
We also studied epithelia containing mixtures of CFTR
ΔF508/ΔF508
and CFTR +/+ cells (Fig. 3E) (Fig. 3  A, B, C , and E). These results with heterozygous epithelia are similar to results obtained with 50:50 mixtures of CF and WT epithelia. , and CFTR +/+ epithelia. Previous studies indicate that the adenovirus vector itself does not affect CFTR function or the function of other epithelial channels (11, 44, 47) .
The vector transduced varying percentages of cells (Fig. S1 ). In epithelia of all three genotypes, HCO 3 − secretion increased to levels greater than levels obtained when we generated epithelia with cells expressing endogenous levels of CFTR. For example, when an epithelium comprised ∼10% CFTR +/+ cells and ∼90% CFTR −/− cells, cAMP-stimulated HCO 3 − secretion was ∼10% of WT levels (Fig. 2 C and D) . In contrast, when a CFTR −/− epithelium comprised ∼10% of transduced cells overexpressing CFTR, cAMPstimulated HCO 3 − secretion was ∼60-70% of WT levels (Fig. 4A) . CFTR overexpression also increased HCO 3 − secretion in WT epithelia. For example, in some epithelia, HCO 3 − secretion approached values almost 400% of CFTR +/+ epithelia. Overexpressing CFTR elevated ASL pH in CF and heterozygous epithelia (Fig. 4B) . However, despite the increase in HCO 3 − secretion, CFTR overexpression did not further increase ASL pH in WT epithelia. These consequences of CFTR overexpression are apparent from an examination of the relationship between cAMP-stimulated HCO 3 − secretion and ASL pH (Fig. 4C ). As HCO 3 − secretion increased above WT levels, there was no additional increase in ASL pH. epithelium are WT or overexpress CFTR, Cl − secretion rises to the level of WT epithelia (10) (11) (12) (13) (14) . However, knowledge that CFTR conducts HCO 3 − (48), that HCO 3 − is the major pH buffer of ASL (49) , and that HCO 3 − secretion plays a key role in airway host defense (31) (32) (33) (34) (35) 50) led us to test the relationship between CFTR expression and HCO 3 − secretion. We found that, unlike Cl − secretion, HCO 3 − secretion was directly proportional to CFTR expression. Direct proportionality was the case for mixing studies, for CFTR +/− epithelia, and for overexpression of CFTR. Different relationships for Cl − secretion and HCO 3 − secretion can be attributed to limitations at the basolateral membrane. Cl − entry into the cell occurs primarily through the basolateral Na (51) . After CFTR reaches >50% of WT levels, Cl − secretion plateaus as Cl − entry into the cell becomes rate-limiting. The fact that the plateau occurs in cell-mixing studies indicates that this phenomenon is not cell autonomous and depends on Cl − movement between cells through gap junctions (10, 13) . In contrast, the relatively proportional relationship between CFTR expression and the rate of HCO 3 − secretion and the ability of CFTR overexpression to further increase the rate of HCO 3 − secretion in WT epithelia indicate that the basolateral membrane is not rate-limiting, even when CFTR expression exceeds WT levels. Perhaps the basolateral membrane is not rate limiting because there are multiple mechanisms for generating intracellular HCO 3 − and basolateral HCO 3 − entry and/or expression of those processes at relatively high levels (52, 53) . Although we cannot exclude the possibility that HCO 3 − does not readily move through gap junctions, this concept seems unlikely given their permeability to charged molecules and many molecules smaller than 500 Da (54).
As HCO 3
− Secretion Increases, ASL pH Reaches a Maximum. Loss of HCO 3 − secretion in the face of continued proton secretion contributes to the abnormally reduced pH of CF ASL (35) . Although increasing HCO 3 − secretion increased ASL pH, pH reached a maximum at ∼7.50. Note that HCO 3 − secretion is a rate, and it was measured with transepithelial voltage clamped at zero. In addition, apical and basolateral solutions had constant and identical pH, HCO 3 − concentration, and other ion concentrations. In contrast, ASL pH is assayed at equilibrium. Consequently, ASL pH is influenced by the transepithelial voltage, transepithelial chemical gradients (including H + and HCO 3 − gradients), and paracellular permselectivities. In addition, changes in the composition of the ASL might have a regulatory influence on transport processes. Those factors, together with the presence and localization of the cellular transport processes, impose a physiologic limitation on the maximum ASL pH (53) .
Reduced HCO 3 − Secretion in CFTR +/− Epithelia May Explain the Risk of Airway Diseases in CF Carriers. The observation that people heterozygous for a CF-causing CFTR mutation had normal rates of airway epithelial Cl − secretion made it difficult to understand why such individuals have an increased risk of airway disease (19) (20) (21) (22) (23) (24) (25) (26) (27) . Our data provide a potential explanation. Compared with WT controls, heterozygous epithelia had a reduced HCO 3 − secretion rate, a reduced ASL pH, and impaired properties associated with airway host defense. Thus, although most CF carriers have no observed lung disease, we speculate that mild impairment of host defense might predispose to airway disease late in life. If that is the case, perhaps increasing HCO 3 − secretion or elevating ASL pH might benefit airway host defense in CF carriers.
This Study Has Advantages and Limitations. An advantage is that we used a porcine model of CF that develops the characteristic features of CF lung disease (29, 30) . To avoid the effects of longterm infection and inflammation, including potential epigenetic changes in epithelial cells, we generated airway epithelia from newborn animals, which we previously showed exhibit airway host defense defects (30, 31, 33) . We found comparable results in CFTR −/− and CFTR ΔF508/ΔF508 epithelia. We examined the effect of multiple interventions to alter HCO 3 − secretion-mixing cells, studying heterozygote epithelia, and overexpressing CFTR. We measured electrolyte secretion and related it to properties associated with host defense.
A limitation of this study is that loss of CFTR may influence the function of other cell types and structures, including submucosal glands (31, 55) , airway smooth muscle (56) , cartilage (57, 58) , and myeloid-derived cells (59) . Impairment of their function might also contribute to the pathogenesis of CF airway disease. It is also possible that, in a mixed epithelium, substances in a WT cell type might modify functions in a CF cell, or the converse. Another limitation is that we do not know which cells (ciliated, goblet, or nonciliated columnar) are most important for HCO 3 − secretion and ASL pH control. Pertinent to our gene transfer studies, adenovirus vectors are reported to transduce all of the cell types in airway epithelia (44, 60) , and we therefore suspect the same occurred in this study. Finally, these studies were done in vitro rather than in vivo. With the development of future animal models, it may be possible to address some of these questions and the consequences for airway disease in vivo.
These Findings Have Implications for Therapy Development. A major challenge for potential gene-and cell-based therapies is targeting a sufficient number of cells. Our data suggest that expressing CFTR at supernormal levels in a small percentage of cells might restore epithelial HCO 3 − secretion, ASL pH, and abnormalities associated with host defense. This rescue might be the case for gene transfer approaches, but it is not likely to occur with genome editing, CFTR mRNA repair, or stem cell transplantation. Thus, for the same numbers of airway cells targeted, our data suggest that there might be greater benefit from gene transfer approaches that overexpress CFTR. However, there are additional considerations. For example, high-level expression can target some CFTR to the basolateral membrane (13) . Basolateral CFTR might be less of a limitation for HCO 3 − than for Cl − secretion; the transepithelial electrochemical gradients for HCO 3 − suggest that basolateral CFTR expression might not have adverse effects on HCO 3 − secretion or ASL pH under equilibrium conditions. Another consideration is that overexpressing CFTR has been reported to inhibit cell proliferation, arrest cell growth, increase cell volume, depolarize the cell membrane, and alter CFTR function (61) (62) (63) .
There are also implications for other potential CF treatments. Our data suggest that the therapeutic window for augmenting CFTR function might be broader than previously thought, extending all of the way from no CFTR function to WT levels of CFTR function. However, increasing CFTR activity above WT levels may not further elevate ASL pH. Nevertheless, previous studies showed that increasing ASL pH above levels observed in WT epithelia further enhances antimicrobial activity and reduces ASL viscosity (32, 34) . Therefore, elevating ASL pH by adding a pH buffer, inhibiting H + secretion, or some other intervention might have additional therapeutic benefit and might be of value in other diseases with a reduced ASL pH.
Materials and Methods
Also see SI Materials and Methods. CFTR −/− (CF), CFTR +/− (heterozygote), and CFTR +/+ (WT) pigs were the product of CFTR +/− matings (28) . CFTR ΔF508/ΔF508 (CF), CFTR +/ΔF508 (heterozygote), and CFTR +/+ pigs were the product of CFTR +/ΔF508 matings (29) . These studies were approved by the University of Iowa Animal Care and Use Committee. Airway epithelial cells from the inferior turbinate were grown at an air-liquid interface as previously described (38) . Epithelia were generated with varying proportions of CF and WT cells and studied at least 14 d after seeding. Nasal epithelia have electrolyte transport characteristics comparable with tracheal/bronchial epithelia (42) . We used standard procedures for quantitative PCR and RT-PCR, Western blots, Ussing chamber analysis of electrolyte transport, fluorescence recovery after photobleaching, measurement of ASL pH, ASL antimicrobial activity, and adenovirus-mediated expression, and GFP quantification. The figures show means ± SEM. Unpaired Student's t test, linear regression, ANOVA, and repeated measures ANOVA were performed when appropriate and as indicated in figure legends. P ≤ 0.05 was considered statistically significant.
